Wang Y - Search Results

1

Phase I/II clinical trial of a Wilms' tumor 1-targeted dendritic cell vaccination-based immunotherapy in patients with advanced cancer.

Zhang W, Lu X, Cui P, Piao C, Xiao M, Liu X, Wang Y, Wu X, Liu J, Yang L. Zhang W, et al. Among authors: wang y. Cancer Immunol Immunother. 2019 Jan;68(1):121-130. doi: 10.1007/s00262-018-2257-2. Epub 2018 Oct 10. Cancer Immunol Immunother. 2019. PMID: 30306202 Free PMC article. Clinical Trial.

2

[The protective effect of Hippophae rhamnoides L. on hyperlipidemic serum cultured smooth muscle cells in vitro].

Wang Y, Lu Y, Liu X, Gou Z, Hu J. Wang Y, et al. Zhongguo Zhong Yao Za Zhi. 1992 Oct;17(10):624-6, 601, inside back cover. Zhongguo Zhong Yao Za Zhi. 1992. PMID: 1294183 Chinese.

3

[Isolation of the lower esophagus and fundus of the stomach by specially designed forceps to avoid ectopic embolization during the process of coronary venous embolizing therapy].

Liu X, Gao H, Wang Y. Liu X, et al. Among authors: wang y. Zhonghua Wai Ke Za Zhi. 1995 Apr;33(4):252-4. Zhonghua Wai Ke Za Zhi. 1995. PMID: 7587685 Chinese.

4

Targeting PD-1 and Tim-3 Pathways to Reverse CD8 T-Cell Exhaustion and Enhance Ex Vivo T-Cell Responses to Autologous Dendritic/Tumor Vaccines.

Liu J, Zhang S, Hu Y, Yang Z, Li J, Liu X, Deng L, Wang Y, Zhang X, Jiang T, Lu X. Liu J, et al. Among authors: wang y. J Immunother. 2016 May;39(4):171-80. doi: 10.1097/CJI.0000000000000122. J Immunother. 2016. PMID: 27070448

5

Tumor antigen-specific CD8⁺ T cells are negatively regulated by PD-1 and Tim-3 in human gastric cancer.

Lu X, Yang L, Yao D, Wu X, Li J, Liu X, Deng L, Huang C, Wang Y, Li D, Liu J. Lu X, et al. Among authors: wang y. Cell Immunol. 2017 Mar;313:43-51. doi: 10.1016/j.cellimm.2017.01.001. Epub 2017 Jan 5. Cell Immunol. 2017. PMID: 28110884

6

Prostaglandin E₂ and PD-1 mediated inhibition of antitumor CTL responses in the human tumor microenvironment.

Miao J, Lu X, Hu Y, Piao C, Wu X, Liu X, Huang C, Wang Y, Li D, Liu J. Miao J, et al. Among authors: wang y. Oncotarget. 2017 Sep 22;8(52):89802-89810. doi: 10.18632/oncotarget.21155. eCollection 2017 Oct 27. Oncotarget. 2017. PMID: 29163789 Free PMC article.

7

Co-inhibition of TIGIT, PD1, and Tim3 reverses dysfunction of Wilms tumor protein-1 (WT1)-specific CD8+ T lymphocytes after dendritic cell vaccination in gastric cancer.

Lu X, Liu J, Cui P, Liu T, Piao C, Xu X, Zhang Q, Xiao M, Liu X, Wang Y, Yang L. Lu X, et al. Among authors: wang y. Am J Cancer Res. 2018 Aug 1;8(8):1564-1575. eCollection 2018. Am J Cancer Res. 2018. PMID: 30210924 Free PMC article.

8

Synergistic effect of adoptive immunotherapy and docetaxel inhibits tumor growth in a mouse model.

Hu Y, Liu J, Cui P, Liu T, Piao C, Xu X, Zhang Q, Xiao M, Lu Y, Liu X, Wang Y, Lu X. Hu Y, et al. Among authors: wang y. Cell Immunol. 2020 Feb;348:104036. doi: 10.1016/j.cellimm.2019.104036. Epub 2019 Dec 31. Cell Immunol. 2020. PMID: 31924315

9

IL-15-induced lymphocytes as adjuvant cellular immunotherapy for gastric cancer.

Hu Y, Liu D, Cui P, Zhang W, Chen H, Piao C, Lu Y, Liu X, Wang Y, Liu J, Lu X. Hu Y, et al. Among authors: wang y. Invest New Drugs. 2021 Dec;39(6):1538-1548. doi: 10.1007/s10637-021-01160-z. Epub 2021 Aug 13. Invest New Drugs. 2021. PMID: 34387808

10

Antibody-dependent cell-mediated cytotoxicity using T cells with NK-like phenotype in combination with avelumab, an anti-PD-L1 antibody.

Liu D, Hu Y, Wei J, Zhang W, Piao C, Lu Y, Wang Y, Liu J, Lu X. Liu D, et al. Among authors: wang y. Immunology. 2022 Oct;167(2):212-220. doi: 10.1111/imm.13530. Epub 2022 Aug 15. Immunology. 2022. PMID: 35751879 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

297,902 results

Search Page

Filters